Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance
Duan Ni, Yun Li, Yuran Qiu, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 5, pp. 336-348
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 137
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 133
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 83
Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy
Duan Ni, Jiacheng Wei, Xinheng He, et al.
Chemical Science (2020) Vol. 12, Iss. 1, pp. 464-476
Open Access | Times Cited: 107
Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators
Shaoyong Lu, Ying-Yi Chen, Jiacheng Wei, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1355-1361
Open Access | Times Cited: 73
Strategies for targeting undruggable targets
Gong Zhang, Juan Zhang, Yuting Gao, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 1, pp. 55-69
Closed Access | Times Cited: 62
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy
Yihui Song, Shu Wang, Min Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3066-3079
Closed Access | Times Cited: 62
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, et al.
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167569-167569
Open Access | Times Cited: 42
Computational approaches for the design of modulators targeting protein-protein interactions
Ashfaq Ur Rehman, Beenish Khurshid, Yasir Ali, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 315-333
Open Access | Times Cited: 31
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Proteomics analysis of histone deacetylase inhibitor-resistant solid tumors reveals resistant signatures and potential drug combinations
Bingbing Hao, Ke Ma, Junyu Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1305-1315
Closed Access | Times Cited: 8
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 7
Along the allostery stream: Recent advances in computational methods for allosteric drug discovery
Duan Ni, Zong‐Tao Chai, Ying Wang, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 4
Closed Access | Times Cited: 49
Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication
Yuran Qiu, Xiaolan Yin, Xinyi Li, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 747-747
Open Access | Times Cited: 46
Mapping cryptic binding sites of drug targets to overcome drug resistance
Yangyang Gao, Wei‐Cheng Yang, Charles R. Ashby, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100934-100934
Closed Access | Times Cited: 15
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Allostery
Mateu Montserrat‐Canals, Gabriele Cordara, Ute Krengel
Quarterly Reviews of Biophysics (2025) Vol. 58
Closed Access
The Evolving Landscape of Protein Allostery: From Computational and Experimental Perspectives
E. Srinivasan, Grigor Arakelov, Nikolay V. Dokholyan
Journal of Molecular Biology (2025), pp. 169060-169060
Closed Access
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025), pp. 101229-101229
Closed Access
NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment
François‐Xavier Cantrelle, Emmanuelle Boll, Lucile Brier, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 48, pp. 25428-25435
Open Access | Times Cited: 35
Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery
Jigang Fan, Yaqin Liu, Ren Kong, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17728-17743
Closed Access | Times Cited: 34
Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics
Sheetal Sharma, Panchali Barman, Shubhi Joshi, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 211, pp. 112303-112303
Open Access | Times Cited: 32
Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance
Shan‐Liang Sun, Shi-Han Wu, Ji-Bo Kang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7415-7437
Closed Access | Times Cited: 25
Learning About Allosteric Drugs and Ways to Design Them
Zhen Wah Tan, Wei-Ven Tee, Igor N. Berezovsky
Journal of Molecular Biology (2022) Vol. 434, Iss. 17, pp. 167692-167692
Closed Access | Times Cited: 24
Targeting allosteric regulation of cancer metabolism
Daniel M. Kremer, Costas A. Lyssiotis
Nature Chemical Biology (2022) Vol. 18, Iss. 5, pp. 441-450
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top